caffeine and butyrolactone i

caffeine has been researched along with butyrolactone i in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hirata, M; Ishizaka, Y; Minemoto, Y; Nakagama, H; Ohtsubo, M; Sasagawa, T; Shimura, M; Uchida, S; Yamashita, K	1

Other Studies

1 other study(ies) available for caffeine and butyrolactone i

Article	Year
Loss of p53 induces M-phase retardation following G2 DNA damage checkpoint abrogation. Archives of biochemistry and biophysics, 2003, Apr-01, Volume: 412, Issue:1 Topics: 4-Butyrolactone; Antineoplastic Agents; Aphidicolin; Blotting, Western; Caffeine; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Cycle; Cyclin B; Cyclin B1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Inhibitors; Flow Cytometry; G2 Phase; Humans; Mitosis; Oncogene Proteins, Viral; Phenotype; Protein Kinases; Protein Serine-Threonine Kinases; Repressor Proteins; S Phase; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2003

Article

Year

Loss of p53 induces M-phase retardation following G2 DNA damage checkpoint abrogation.

Archives of biochemistry and biophysics, 2003, Apr-01, Volume: 412, Issue:1

Topics: 4-Butyrolactone; Antineoplastic Agents; Aphidicolin; Blotting, Western; Caffeine; CDC2 Protein Kinase; CDC2-CDC28 Kinases; Cell Cycle; Cyclin B; Cyclin B1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Enzyme Inhibitors; Flow Cytometry; G2 Phase; Humans; Mitosis; Oncogene Proteins, Viral; Phenotype; Protein Kinases; Protein Serine-Threonine Kinases; Repressor Proteins; S Phase; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2003